Timothy Eugene Sullivan sold $280K of Apellis Pharmaceuticals (APLS)

Executed Oct 21 2025, disclosed Oct 23 2025, 2 days later.

Value, as filed

$280K

10,000 sh × $28.03

Executed

Oct 21 2025

the trade date, as filed

Disclosed

Oct 23 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TS Timothy Eugene Sullivan Chief Financial Officer profile →

Timothy Eugene Sullivan (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in APLS. The largest single filing was $280K of APLS (10,000 sh × $28.03, as filed), executed Oct 21 2025.

The name

APLS APLS APLS · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Timothy Eugene Sullivan in APLS

APLSSALE Apellis Pharmaceuticals, Inc. $224K
10,287 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $1.2M
42,729 sh across 2 lots
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET